Oncotelic Therapeutics, Inc. Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q4 2011 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Oncotelic Therapeutics, Inc. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q4 2011 to Q4 2023.
  • Oncotelic Therapeutics, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was $13.4M, a 77.3% decline year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $13.4M -$45.5M -77.3% Dec 31, 2023 10-K 2024-04-12
Q4 2022 $58.9M -$8.82M -13% Dec 31, 2022 10-K 2024-04-12
Q4 2021 $67.7M +$822K +1.23% Dec 31, 2021 10-K/A 2023-04-20
Q3 2021 $67.6M Sep 30, 2021 10-Q 2021-11-22
Q2 2021 $67.1M Jun 30, 2021 10-Q 2021-08-20
Q1 2021 $66.3M Mar 31, 2021 10-Q 2021-05-24
Q4 2020 $66.9M +$1.5M +2.3% Dec 31, 2020 10-K 2022-04-15
Q4 2019 $65.4M +$2.46M +3.91% Dec 31, 2019 10-K 2021-04-15
Q4 2018 $62.9M +$590K +0.95% Dec 31, 2018 10-K 2019-04-10
Q4 2017 $62.3M -$29.2M -31.9% Dec 31, 2017 10-K 2019-04-10
Q4 2016 $91.5M +$4.76M +5.48% Dec 31, 2016 10-K 2018-04-17
Q4 2015 $86.8M +$4.3M +5.22% Dec 31, 2015 10-K 2017-03-30
Q4 2014 $82.5M +$3.88M +4.94% Dec 31, 2014 10-K 2016-03-25
Q4 2013 $78.6M +$2.64M +3.48% Dec 31, 2013 10-K 2015-03-30
Q4 2012 $75.9M -$195K -0.26% Dec 31, 2012 10-K 2014-03-20
Q4 2011 $76.1M Dec 31, 2011 10-K 2013-03-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.